Skip to main content

Animations

MJFF Publications

6861 - 6870 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2019
  • 2015
  • 2019
  • 2018
  • 2017
  • 2025
  • 2018
  • 2019
  • 2020
  • Summary Details
    OPEN
    Title: Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-21669-4
    Citation Count: 166
  • Summary Details
    OPEN
    Title: Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm
    Journal Name: Oncogene
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41388-019-0895-2
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/cb5010417
    Citation Count: 55
  • Summary Details
    RESTRICTED
    Title: Physiotherapy improves motor function in patients with the Parkinson variant of multiple system atrophy: A prospective trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.026
    Citation Count: 32
  • Summary Details
    OPEN
    Title: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Novel conformation‐selective alpha‐synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease
    Journal Name: Neuropathology and Applied Neurobiology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/nan.12402
    Citation Count: 60
  • Summary Details
    OPEN
    Title: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulation
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-025-95679-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awy072
    Citation Count: 191
  • Summary Details
    RESTRICTED
    Title: Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.020
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27993
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.